Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress

Yalçın Erzurumlu; Hatice Kübra Doğan; Deniz Çataklı

Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress

Abstract

Inflammation-induced overexpression of cytokines can lead to cell death by caspase-dependent or independent signaling pathways. Numerous natural products are used to suppress/re-modulate inflammation. Phenolic monoterpene thymol is widely used in cosmetics and for medical purposes. It has been shown that thymol regulates the anti-inflammatory, antioxidant and anti-apoptotic responses in lipopolysaccharide (LPS)-induced in vitro and in vivo models. However, there is still a need to investigate the molecular mechanism of inflammation and the detailed regulatory roles of thymol on inflammation-dependent signaling mechanisms. In the present study, the possible protective effects of thymol on inflammation-mediated lysosomal stress in the LPS-induced acute kidney inflammation model were investigated on HEK293 cells. To mimic the inflammation in HEK293 cells, LPS was applied to the cells for 24 h. Following, cells were treated with various doses of thymol and total protein was isolated from the cells. Inflammation-associated interleukin-6 (IL-6), tumor necrosis factor-⍺ (TNF-⍺), nuclear factor kappa B (Nf-κB) and phospho-Nf-κB protein levels, autophagy-related Beclin-1, autophagy-related 5 (Atg5), p62/SQSTM1 and microtubule-associated protein 1A/1B-light chain 3 (LC3-I/II), ubiquitin proteasome system-associated polyubiquitin, cell death-associated caspase-3 and poly (ADP-ribose) polymerase (PARP-1) protein levels were examined by immunoblotting. We found that LPS-induced acute inflammation caused the suppressing of autophagic flux and reducing degradation of polyubiquitinated proteins. Thymol treatment markedly reversed the suppression of autophagy and stacking of poly-ubiquitinated protein by LPS. While, LPS-induced acute inflammation did not cause caspase activation, it caused an increase in lysosomal stress-related PARP-1 cleavage pattern and thymol administration efficiently reduced PARP-1 cleavage. Our results suggested that LPS-induced acute inflammation triggers blockage of autophagic flux and thymol has a protective role against LPS-induced lysosomal stress

Keywords

References

[1] Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45. [CrossRef]
[2] Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004;6(3):203–8. [CrossRef]
[3] Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Archiv. 2005;446(5),475–82. [CrossRef]
[4] Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18(18):2195–224. [CrossRef]
[5] Fehrenbacher N, Bastholm L, Kirkegaard-Sørensen T, Rafn B, Bøttzauw T, Nielsen C, et al. Sensitization to the Lysosomal Cell Death Pathway by Oncogene-Induced Down-regulation of Lysosome-Associated Membrane Proteins 1 and 2. Cancer Research. 2008;68: 6623–33. [CrossRef]
[6] Karch J, Schips TG, Maliken BD, Brody MJ, Sargent MA, Kanisicak O, et al. Autophagic cell death is dependent on lysosomal membrane permeability through Bax and Bak. Elife. 2017;6. [CrossRef]
[7] Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008;27(50): 6434–6451. [CrossRef]
[8] Wu Y, Sun Y, Dong X, Chen J, Wang Z, Chen J, et al. The Synergism of PGN, LTA and LPS in Inducing Transcriptome Changes, Inflammatory Responses and a Decrease in Lactation as Well as the Associated Epigenetic Mechanisms in Bovine Mammary Epithelial Cells. Toxins. 2020;12(6): 387. [CrossRef]

[9] Cao X, Jin Y, Zhang H, Yu L, Bao X, Li F, et al. The Anti-inflammatory Effects of 4-((5-Bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic Acid in Lipopolysaccharide-Activated Primary Microglial Cells. Inflammation. 2018;41(2):530–40. [CrossRef]
[10] Rahmani AH, Al Zohairy MA, Aly SM, Khan MA. Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways. Biomed Res Int. 2014;2014:761608. [CrossRef]
[11] Akbar S. Thymus vulgaris L. (Lamiaceae) Handbook of 200 Medicinal Plants. 2020, p. 1795–810. [CrossRef]
[12] Basch E, Ulbricht C, Hammerness P, Bevins A, Sollars D. Thyme (Thymus vulgarisL.), Thymol. Vol. 4, Journal of Herbal Pharmacotherapy. 2004;4(1): 49-67. [CrossRef]
[13] Marchese A, Orhan IE, Daglia M, Barbieri R, Di Lorenzo A, Nabavi SF, et al. Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chem. 2016;210:402–14. [CrossRef]
[14] Rustaiyan A, Masoudi S, Monfared A, Kamalinejad M, Lajevardi T, Sedaghat S, et al. Volatile constituents of three Thymus species grown wild in Iran. Planta Med. 2000;66(2):197–8. [CrossRef]
[15] Soliman KM, Badeaa RI. Effect of oil extracted from some medicinal plants on different mycotoxigenic fungi. Food Chem Toxicol. 2002;40(11):1669–75. [CrossRef]
[16] Lee SP, Buber MT, Yang Q, Cerne R, Cortés RY, Sprous DG, et al. Thymol and related alkyl phenols activate the hTRPA1 channel. Br J Pharmacol. 2008;153(8):1739–49. [CrossRef]
[17] Yang J, Hooper WC, Phillips DJ, Talkington DF. Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific. Microb Pathog. 2003;34(1):17–25. [CrossRef]
[18] Yao L, Hou G, Wang L, Zuo XS, Liu Z. Protective effects of thymol on LPS-induced acute lung injury in mice. Microbial Pathogenesis. 2018;116: 8–12. [CrossRef]
[19] El-Sayed EM, Abd-Allah AR, Mansour AM, El-Arabey AA. Thymol and carvacrol prevent cisplatin-induced nephrotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats. J Biochem Mol Toxicol. 2015;29(4):165–72. [CrossRef]
[20] Elbe H, Yigitturk G, Cavusoglu T, Uyanikgil Y, Ozturk F. Apoptotic effects of thymol, a novel monoterpene phenol, on different types of cancer. Bratisl Lek Listy. 2020;121(2):122–8. [CrossRef]
[21] Yücel G, Zhao Z, El-Battrawy I, Lan H, Lang S, Li X, et al. Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes. Sci Rep. 2017;7(1):1–13. [CrossRef]
[22] Tucureanu MM, Rebleanu D, Constantinescu CA, Deleanu M, Voicu G, Butoi E, et al. Lipopolysaccharide-induced inflammation in monocytes/macrophages is blocked by liposomal delivery of G-protein inhibitor. Int J Nanomedicine. 2018;13:63–76. [CrossRef]
[23] Liu X, Yin S, Chen Y, Wu Y, Zheng W, Dong H, et al. LPS‑induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF‑κB, STAT3 or AP‑1 activation. Mol Med Rep. 2018;17(4):5484–91. [CrossRef]
[24] Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2. [CrossRef]
[25] Klionsky DJ, Emr SD. Autophagy as a Regulated Pathway of Cellular Degradation. Science.2000;290(5497):1717-1721. [CrossRef]
[26] Nandi D, Tahiliani P, Kumar A, Chandu D. The ubiquitin-proteasome system. J Biosci. 2006;31(1):137–55. [CrossRef]
[27] Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell. 2009;33(4):517–27. [CrossRef]
[28] Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366(6467):818–822. [CrossRef]
[29] Wang XJ, Yu J, Wong SH, Cheng ASL, Chan FKL, Ng SSM, et al. A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy. Autophagy. 2013;9(10):1500–8. [CrossRef]
[30] Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett. 2016;21:29. [CrossRef]
[31] Nicoletti VG, Stella AMG. Role of PARP Under Stress Conditions: Cell Death or Protection?.Neurochemical Research. 2003;28(2):187–94. [CrossRef]
[32] Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem. 1994; 269(49):30761–4. [CrossRef]
[33] Maiden MJ, Otto S, Brealey JK, Finnis ME, Chapman MJ, Kuchel TR, et al. Structure and Function of the Kidney in Septic Shock. A Prospective Controlled Experimental Study. Am J Respir Crit Care Med. 2016;194(6):692–700. [CrossRef]
[34] Wang Z, Holthoff JH, Seely KA, Pathak E, Spencer HJ 3rd, Gokden N, et al. Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol. 2012;180(2):505–16. [CrossRef]
[35] Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949–64. [CrossRef]
[36] Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, et al. KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis. 2013;62(5):849–59. [CrossRef]
[37] Hoste EAJ. Epidemiology of Acute Kidney Injury in Critically Ill Patients. In Critical Care Nephrology. 2019, p. 81–85. [CrossRef]
[38] Chauhan AK, Jakhar R, Paul S, Kang SC. Potentiation of macrophage activity by thymol through augmenting phagocytosis. Int Immunopharmacol. 2014;18(2):340–6.[CrossRef]
[39] Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci U S A. 2006; 103(41):15136–41. [CrossRef]
[40] Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol. 2007;8:1. [CrossRef]
[41] Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). The FASEB Journal. 1990;4: 2860–2867. [CrossRef]
[42] Hochrainer K, Racchumi G, Anrather J. Site-specific phosphorylation of the p65 protein subunit mediates selective gene expression by differential NF-κB and RNA polymerase II promoter recruitment. J Biol Chem. 2013;288(1):285–93. [CrossRef]
[43] Anrather J, Racchumi G, Iadecola C. cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-kappa B. J Biol Chem. 2005;280(1):244–52. [CrossRef]
[44] Wu H, Jiang K, Yin N, Ma X, Zhao G, Qiu C, et al. Thymol mitigates lipopolysaccharide-induced endometritis by regulating the TLR4- and ROS-mediated NF-κB signaling pathways. Oncotarget. 2017;8(12):20042–55. [CrossRef]
[45] Qian M, Fang X, Wang X. Autophagy and inflammation. Clinical and Translational Medicine. 2017;6(1):1-11. [CrossRef]
[46] Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 2013;13(10):722–37. [CrossRef]
[47] Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, Ron D, et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol. 2007;171(2):513–24. [CrossRef]
[48] Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010;8:31. [CrossRef]
[49] Artal-Sanz M, Samara C, Syntichaki P, Tavernarakis N. Lysosomal biogenesis and function is critical for necrotic cell death in Caenorhabditis elegans. J Cell Biol. 2006;173(2):231–9. [CrossRef]
[50] Ivanova S, Repnik U, Boji L, Petelin A, Turk V, Turk B. Chapter Nine Lysosomes in Apoptosis. Programmed Cell Death, General Principles forStudying Cell Death, Part A. 2008;442: 183–199. [CrossRef]
[51] Pacheco FJ, Servin J, Dang D, Kim J, Molinaro C, Daniels T, et al. Involvement of lysosomal cathepsins in the cleavage of DNA topoisomerase I during necrotic cell death. Arthritis Rheum. 2005;52(7):2133–45. [CrossRef]
[52] He C, Klionsky DJ. Regulation Mechanisms and Signaling Pathways of Autophagy. Annual Review of Genetics. 2009;43: 67–93. [CrossRef]
[53] Wen YD, Sheng R, Zhang LS, Han R, Zhang X, Zhang XD, et al. Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy. 2008;4(6):762–9. [CrossRef]
[54] Gobeil S, Boucher CC, Nadeau D, Poirier GG. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 2001;8(6):588–94. [CrossRef]

Details

Primary Language

English

Subjects

Pharmaceutical Biochemistry

Journal Section

Research Article

Authors

Yalçın Erzurumlu ^*
0000-0001-6835-4436
Türkiye

Hatice Kübra Doğan
0000-0002-6061-1300
Türkiye

Deniz Çataklı
0000-0001-7327-5396
Türkiye

Publication Date

June 28, 2025

Submission Date

June 14, 2022

Acceptance Date

August 19, 2022

Published in Issue

Year 2023 Volume: 27 Number: 1

IZ

https://izlik.org/JA54RU76PK

Cite

RIS / Bibtex

APA

Erzurumlu, Y., Doğan, H. K., & Çataklı, D. (2025). Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress. Journal of Research in Pharmacy, 27(1), 375-385. https://izlik.org/JA54RU76PK

AMA

1.Erzurumlu Y, Doğan HK, Çataklı D. Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress. J. Res. Pharm. 2025;27(1):375-385. https://izlik.org/JA54RU76PK

Chicago

Erzurumlu, Yalçın, Hatice Kübra Doğan, and Deniz Çataklı. 2025. “Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress”. Journal of Research in Pharmacy 27 (1): 375-85. https://izlik.org/JA54RU76PK.

EndNote

Erzurumlu Y, Doğan HK, Çataklı D (June 1, 2025) Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress. Journal of Research in Pharmacy 27 1 375–385.

IEEE

[1]Y. Erzurumlu, H. K. Doğan, and D. Çataklı, “Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress”, J. Res. Pharm., vol. 27, no. 1, pp. 375–385, June 2025, [Online]. Available: https://izlik.org/JA54RU76PK

ISNAD

Erzurumlu, Yalçın - Doğan, Hatice Kübra - Çataklı, Deniz. “Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress”. Journal of Research in Pharmacy 27/1 (June 1, 2025): 375-385. https://izlik.org/JA54RU76PK.

JAMA

1.Erzurumlu Y, Doğan HK, Çataklı D. Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress. J. Res. Pharm. 2025;27:375–385.

MLA

Erzurumlu, Yalçın, et al. “Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress”. Journal of Research in Pharmacy, vol. 27, no. 1, June 2025, pp. 375-8, https://izlik.org/JA54RU76PK.

Vancouver

1.Yalçın Erzurumlu, Hatice Kübra Doğan, Deniz Çataklı. Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress. J. Res. Pharm. [Internet]. 2025 Jun. 1;27(1):375-8. Available from: https://izlik.org/JA54RU76PK